Compounds > levodopa
Page last updated: 2024-08-17

levodopa and nociceptin

levodopa has been researched along with nociceptin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Brown, JM; Buzas, B; Candeletti, S; Cox, BM; Di Benedetto, M; Fantin, M; Guerrini, R; Marti, M; Mela, F; Morari, M; Reinscheid, RK; Romualdi, P; Salvadori, S; Simonato, M; Witta, J; Zucchini, S1
Brotchie, JM; de Bie, RM; Fox, SH; Johnston, TH; McCreary, AC; Visanji, NP1
Marti, M; Morari, M; Viaro, R1
Bezard, E; Brambilla, R; Calabresi, P; Fasano, S; Guerrini, R; Li, Q; Marti, M; Morari, M; Morella, I; Rodi, D; Simonato, M; Tozzi, A1
Borrelli, E; Calcagno, M; Marti, M; Morari, M; Viaro, R1
Bezard, E; Eleopra, R; Mercatelli, D; Morari, M; Zaveri, NT1
Brambilla, R; Brugnoli, A; Fasano, S; Mazzocchi, M; Mercatelli, D; Morari, M; Morella, I; Neubig, RR; O'Keeffe, GW; Pisanò, CA; Zaveri, NT1

Reviews

1 review(s) available for levodopa and nociceptin

ArticleYear
Managing Parkinson's disease: moving ON with NOP.
    British journal of pharmacology, 2020, Volume: 177, Issue:1

    Topics: Animals; Antiparkinson Agents; Clinical Trials as Topic; Dopamine; Dopaminergic Neurons; Humans; Levodopa; Nociceptin; Nociceptin Receptor; Opioid Peptides; Parkinson Disease; Receptors, Opioid; Substantia Nigra

2020

Other Studies

6 other study(ies) available for levodopa and nociceptin

ArticleYear
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005, Oct-19, Volume: 25, Issue:42

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Degeneration; Nociceptin; Opioid Peptides; Parkinson Disease; Rats; Rats, Sprague-Dawley; Synaptic Transmission

2005
The nociceptin/orphanin FQ (NOP) receptor antagonist J-113397 enhances the effects of levodopa in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2008, Oct-15, Volume: 23, Issue:13

    Topics: Analysis of Variance; Animals; Antiparkinson Agents; Benzimidazoles; Callithrix; Disability Evaluation; Disease Models, Animal; Drug Synergism; Levodopa; MPTP Poisoning; Nociceptin; Opioid Peptides; Piperidines; Time Factors

2008
Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockade.
    Experimental neurology, 2010, Volume: 223, Issue:2

    Topics: Amisulpride; Animals; Antiparkinson Agents; Benzimidazoles; Benzothiazoles; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Drug Synergism; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neural Inhibition; Nociceptin; Opioid Peptides; Parkinsonian Disorders; Piperidines; Pramipexole; Pyridines; Reaction Time; Receptors, Dopamine D3; Sulpiride

2010
Nociceptin/orphanin FQ receptor agonists attenuate L-DOPA-induced dyskinesias.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Nov-14, Volume: 32, Issue:46

    Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Autoradiography; Behavior, Animal; Dyskinesia, Drug-Induced; Electrophysiological Phenomena; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Glutamic Acid; Levodopa; Macaca; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Microinjections; Nociceptin; Opioid Peptides; Oxidopamine; Postural Balance; Rats; Rats, Sprague-Dawley; Rats, Wistar

2012
Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands.
    Neuropharmacology, 2013, Volume: 72

    Topics: Analgesics, Opioid; Animals; Carbamates; Catalepsy; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Levodopa; Ligands; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Morphine; Motor Activity; Nociceptin; Opioid Peptides; Receptors, Dopamine D2; Rotarod Performance Test

2013
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced dyskinesia.
    British journal of pharmacology, 2023, Volume: 180, Issue:7

    Topics: Analgesics, Opioid; Animals; Dyskinesia, Drug-Induced; HEK293 Cells; Humans; Levodopa; Mice; Nociceptin; Rats; Receptors, Opioid; Signal Transduction

2023